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Thalassemia also known as anemia cause by the dysfunction of globin
production ， early cases come from the Mediterranean region ， so is called
thalassemia，It is one of the largest single-gene disorders in the worldwide，follow
Mendel's genetics law。The disease is caused by a deletion or point mutations in
globin gene, according to the peptide chain of variation， it can be divided into
α-thalassemia and β-thalassemia。Due to the complexity and diverse of the genetic
defects,, so the type of the globin chain, the clinical symptoms varied greatly。There
no effective treatments for moderateand severe Mediterraneanin clinical practice，
which bring a heavy economic and mental burden to the community, family and
individuals。Therefore, check out the Mediterranean anemia patients effectively、
conduct premarital and preconception guidance、prenatal diagnosis, to avoid the birth
of the children with thalassemia, has an extremely important social significance.
The most commonly used methods in clinical screening is blood and red blood
cell fragility test, capillary electrophoresis, high performance liquid chromatography.
The results of the hematology can not confirmed whether one with
Mediterranean anemia,genetic diagnosis is still a definite diagnosis.Currently ，
mediterranean anemia gene diagnostic methods widely used in clinical is based on
basic PCR technique,The basic principle is based on the specific primers, probes to
detect globin gene mutations and deletions.There are Gap-PCR technology、reverse
dot blot hybridization、 amplification refractory mutation system、 high-resolution
melting curve analysis、multiplex ligation-dependent probe amplification、gene chips
and so on.These genetic diagnostic methods have advantages and disadvantages, their
common denominator is only detect the known mutations, but powerless for the
mutation still unknown。Based on the pros and cons of various diagnosis methods and
experimental conditions， when choosing diagnostic methods, we should take a















We take genetic tests for hospitalized patients、clinic patients、healthy physical
examination personnel from January 2013 to August 2014,A total of 3715 cases.We
found that there still a certain percentage of thalassemia gene test negative in the
abnormal blood group.While we can not help but ponder that even there are rapid
development of molecular diagnosti techniques in the past decades,
thalassemia-related molecular diagnostic technology has become more sophisticated,
but it does not detect all thalassemia mutation sites, there is a leak screening for
thalassemia, which resulting in the birth of high-risk children of thalassemia.
In recent years, high throughput sequencing technology got rapid
development,the technology can be a parallel for hundreds of thousands to one
million DNA molecules, has the advantages of high flux, high speed.With its costs
continue to decrease, technology continues to improve,it has been widely used in
clinical and research studies. This technology can be applied to specific clinical
detection of Mediterranean anemia in a variety of mutations.In this paper, we mainly
research how to use next-generation sequencing to detect thalassemia,and to study the
feasibility.The test were found in two cases of mutation, in one case for the new
mutation.




















































































血红蛋白 H病 ——/—α 1/4
Bart’s综合征 ——/—— 0
β 珠 蛋 白 基 因 位 于 11 号 染 色 体 短 臂 上 ， 其 基 因 排 列 顺 序 为
5'—ε—Gγ—Aγ—ψβ1—δ—β—3'，覆盖 70kb，从 5'→3'，依次为胚胎期表达的ε
基因，胎儿期表达的γ基因，成年时表达的β 和 δ，无表达且为假基因状态ψβ2




























Name HGVS nomenclature Name HGVS nomenclature
-87 (C->T) HBB:c.-137C>T -28 (A->G) HBB:c.-78A>G
-86 (C->G) HBB:c.-136C>G -28 (A->C) HBB:c.-78A>C
-86 (C->A) HBB:c.-136C>A -26 A>C HBB:c.-76A>C
-71 (C>T) HBB:c.-121C>T -25 (G>C) HBB:c.-75G>C
-50 G>A HBB:c.-100G>A CAP +1 (A->C) HBB:c.-50A>C
-32 (C>T) HBB:c.-82C>T 5'UTR; +22 (G->A) HBB:c.-29G>A
-32 (C->A) HBB:c.-82C>A 5'UTR; +33 (C->G) HBB:c.-18C>G
-31 (A->G) HBB:c.-81A>G Initiation CDA >G HBB:c.1A>G
-31 (A->C) HBB:c.-81A>C Initiation CDT>A HBB:c.2T>A
-30 (T->A) HBB:c.-80T>A Initiation CDT>C HBB:c.2T>C
-30 T>G HBB:c.-80T>G Initiation CDT>G HBB:c.2T>G
-30 (T->C) HBB:c.-80T>C Initiation CDG>A HBB:c.3G>A
-29 (A->G) HBB:c.-79A>G Initiation CDG>T HBB:c.3G>T
CD17 (A->T) HBB:c.52A>T IVS-I-128 (T->G) HBB:c.93-3T>G
Hb Malay HBB:c.59A>G IVS-I-129 (A>G) HBB:c.93-2A>G
CD22 (G->T) HBB:c.67G>T IVSI-129 (A>C) HBB:c.93-2A>C
CD24 (T->A) HBB:c.75T>A IVS-I-130 (G->C) HBB:c.93-1G>C
CD26 (G->T) HBB:c.79G>T IVS-I-130 (G->A) HBB:c.93-1G>A
Hb E HBB:c.79G>A CD30AGG->AGC HBB:c.93G>C
Hb Knossos HBB:c.82G>T Hb Medicine Lake HBB:c.[295G>A;98T>A
Hb Chesterfield HBB:c.86T>G CD35 (C->A) HBB:c.108C>A
CD29 (C->T) HBB:c.90C>T CD37 (TGG>TAG) HBB:c.113G>A















Name HGVS nomenclature Name HGVS nomenclature
CD30 A>C HBB:c.91A>C CD39 (C->T) HBB:c.118C>T
Hb Monroe HBB:c.92G>C CD43 (G->T) HBB:c.130G>T
IVS-I -1 (G->A) HBB:c.92G>A CD59 A>T HBB:c.178A>T
IVS-I-1 (G->A) HBB:c.92+1G>A Hb Cagliari HBB:c.182T>A
IVS-I-1 (G->T) HBB:c.92+1G>T CD61 (A->T) HBB:c.184A>T
IVS-I-2 (T->A) HBB:c.92+2T>A CD90 (G->T) HBB:c.271G>T
IVS-I-2 (T->G) HBB:c.92+2T>G IVS II-1 (G>T) HBB:c.315+1G>T
IVS-I-2 (T->C) HBB:c.92+2T>C IVS-II-1 (G->A) HBB:c.315+1G>A
IVS-I-5 (G->A) HBB:c.92+5G>A IVS-II-1 (G->C) HBB:c.315+1G>C
IVS-I-5 (G->C) HBB:c.92+5G>C IVS II-2 (T>C) HBB:c.315+2T>C
IVS-I-5 (G->T) HBB:c.92+5G>T IVS-II-2 (T>A) HBB:c.315+2T>A
IVS-I-5 (G->A) HBB:c.92+5G>A IVS-II-5 (G->C) HBB:c.315+5G>C
IVS-I-6 (T->C) HBB:c.92+6T>C IVS-II-654 (C->T) HBB:c.316-197C>T
IVS I-7 (A>T) HBB:c.92+7A>T IVS-II-705 (T->G) HBB:c.316-146T>G
IVS-I-110 (G->A) HBB:c.93-21G>A IVS II-726 (A>G) HBB:c.316-125A>G
IVS-I-116 (T->G) HBB:c.93-15T>G IVS-II-745 (C->G) HBB:c.316-106C>G
IVS II-761 A>G HBB:c.316-90A>G Poly A (A->G) HBB:c.*112A>G
IVS2-781 C>G HBB:c.316-70C>G Poly A (A) HBB:c.*112A>T
IVS-II-837 (T->G) HBB:c.316-14T>G Poly A (A->G) HBB:c.*113A>G





IVS-II-844 (C->G) HBB:c.316-7C>G HbAntalya HBB:c.16delC;8_9insC
IVS-II-848 (C->A) HBB:c.316-3C>A CDS 8/9 (+AGAA) HBB:c.23_26dup
IVS-II-848 (C->G) HBB:c.316-3C>G CDS 7/8 (+G) HBB:c.24_25insG
IVS-II-849 (A->C) HBB:c.316-2A>C CDS 8/9 (+G) HBB:c.27_28insG
IVS-II-849 (A->G) HBB:c.316-2A>G CDS 9/10 (+T) HBB:c.30_31insT
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